MRNA
(NASDAQ)Moderna, Inc.
$63.32-- (--)
Loading... - Market loading
Moderna (MRNA) Stock Price & Financial Analysis
Moderna Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$60.82 - $63.78
52-Week High$85.60
52-Week Low$22.28
Open$62.89
Volume4.69M
Average Volume (3M)6.36M
Market Cap25.20B
Shares Outstanding398.00M
Price to Sales (P/S)10.57
Price to Book (P/B)3.48
EV/EBITDA-7.60
Revenue (TTM)2.23B
Net Income (TTM)-3.15B
Free Cash Flow (TTM)-1.22B
EPS (TTM)$-8.00
Profit Margin-141.43%
Operating Margin-149.01%
Return on Equity (ROE)-46.61%
Debt to Equity0.09
50-Day MA$59.54
200-Day MA$45.75
52-Week Change126.53%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$60.82 - $63.78
52-Week High$85.60
52-Week Low$22.28
Open$62.89
Volume4.69M
Average Volume (3M)6.36M
Market Cap25.20B
Shares Outstanding398.00M
Price to Sales (P/S)10.57
Price to Book (P/B)3.48
EV/EBITDA-7.60
Revenue (TTM)2.23B
Net Income (TTM)-3.15B
Free Cash Flow (TTM)-1.22B
EPS (TTM)$-8.00
Profit Margin-141.43%
Operating Margin-149.01%
Return on Equity (ROE)-46.61%
Debt to Equity0.09
50-Day MA$59.54
200-Day MA$45.75
52-Week Change126.53%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Moderna
What is the current stock price for MRNA?
As of the latest trading session, MRNA stock trades at $63.32. The 52-week range is $22.28–$85.60, with a day range of $60.82–$63.78.
What is the P/E ratio for MRNA?
The P/E ratio (Price-to-Earnings) for MRNA is shown in the Key Statistics section. This valuation metric helps compare Moderna, Inc. to industry peers.
Does MRNA pay dividends?
Moderna does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MRNA?
Based on 15 analysts, the consensus for MRNA is Hold.
What is the market cap of MRNA?
Moderna's market capitalization is $25.20B, classifying it as a large-cap company. Moderna operates in the Healthcare sector within the Biotechnology industry.